Lv4
694 积分 2022-06-29 加入
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
5个月前
已完结
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
5个月前
已完结
Current status and future perspectives in HER2 positive advanced gastric cancer
5个月前
已完结
Current status and future perspectives in HER2 positive advanced gastric cancer
6个月前
已完结
Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients
7个月前
已完结
Antibody–drug conjugates in gastric cancer: clinical advances and resistance mechanisms
7个月前
已完结
Antibody–drug conjugates come of age in oncology
7个月前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
7个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
8个月前
已完结
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
8个月前
已完结
皖公网安备34019202002308
